NG2 cells, a new trail for Alzheimer's disease mechanisms?

Acta Neuropathologica Communications

Volumn 2, Issue 1, 2014, Pages

  Nielsen, Henrietta M ^a,b   Ek, Danyal ^a   Avdic, Una ^a   Orbjörn, Camilla ^a   Hansson, Oskar ^c   Veerhuis, Robert ^e   Rozemuller, Annemieke J M ^e   Brun, Arne ^f   Minthon, Lennart ^a,c   Wennström, Malin ^a  

^a LUND UNIVERSITY   (Sweden)

^b MAYO CLINIC   (United States)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d NETHERLANDS BRAIN BANK   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f LUND UNIVERSITY   (Sweden)

Author keywords

Alzheimer's disease; Amyloid beta; Brain tissue; Cell culture; Cerebrospinal fluid; NG2 cells

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); ANTIGEN; BIOLOGICAL MARKER; CHONDROITIN SULFATE PROTEOGLYCAN 4; MAPT PROTEIN, HUMAN; PEPTIDE FRAGMENT; PROTEOGLYCAN; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; AMYLOID PLAQUE; ASTROCYTE; BRAIN; CELL CULTURE; CELL SURVIVAL; CEREBROSPINAL FLUID; FEMALE; GLIA; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANTIGENS; ASTROCYTES; BIOLOGICAL MARKERS; BRAIN; CELL SURVIVAL; CELLS, CULTURED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROGLIA; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PLAQUE, AMYLOID; PROTEOGLYCANS; TAU PROTEINS;

EID: 85005808157     PISSN: None     EISSN: 20515960     Source Type: Journal    
DOI: 10.1186/2051596017     Document Type: Article

References (72)

1. Nishiyama A, Dahlin KJ, Prince JT, Johnstone SR, Stallcup WB: The primary structure of NG2, a novel membrane-spanning proteoglycan. J Cell Biol 1991,114(2):359-371. 10.1083/jcb.114.2.359
2. Staugaitis SM, Trapp BD: NG2-positive glia in the human central nervous system. Neuron Glia Biol 2009,5(3-4):35-44. 10.1017/S1740925X09990342
3. Nishiyama A, Chang A, Trapp BD: NG2+ glial cells: a novel glial cell population in the adult brain. J Neuropathol Exp Neurol 1999,58(11):1113-1124. 10.1097/00005072-199911000-00001
4. Ong WY, Levine JM: A light and electron microscopic study of NG2 chondroitin sulfate proteoglycan-positive oligodendrocyte precursor cells in the normal and kainate-lesioned rat hippocampus. Neuroscience 1999,92(1):83-95. http://www.ncbi.nlm.nih.gov/pubmed/10392832 10.1016/S0306-4522(98)00751-9
5. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD: NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neuroscience: Official J Soc Neurosci 2000,20(17):6404-6412.
6. Nishiyama A: NG2 cells in the brain: a novel glial cell population. Hum Cell 2001,14(1):77-82.
7. Butt AM, Hamilton N, Hubbard P, Pugh M, Ibrahim M: Synantocytes: the fifth element. J Anat 2005,207(6):695-706. 10.1111/j.1469-7580.2005.00458.x
8. Asher RA, Morgenstern DA, Properzi F, Nishiyama A, Levine JM, Fawcett JW: Two separate metalloproteinase activities are responsible for the shedding and processing of the NG2 proteoglycan in vitro. Mol Cell Neurosci 2005,29(1):82-96. 10.1016/j.mcn.2005.02.001
9. Bu J, Akhtar N, Nishiyama A: Transient expression of the NG2 proteoglycan by a subpopulation of activated macrophages in an excitotoxic hippocampal lesion. Glia 2001,34(4):296-310. 10.1002/glia.1063
10. Fiedorowicz A, Figiel I, Zaremba M, Dzwonek K, Oderfeld-Nowak B: The ameboid phenotype of NG2 (+) cells in the region of apoptotic dentate granule neurons in trimethyltin intoxicated mice shares antigen properties with microglia/macrophages. Glia 2008,56(2):209-222. 10.1002/glia.20605
11. Jones LL, Yamaguchi Y, Stallcup WB, Tuszynski MH: NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J Neuroscience: Official J Soc Neurosci 2002,22(7):2792-2803. http://www.ncbi.nlm.nih.gov/pubmed/11923444
12. Ozerdem U, Monosov E, Stallcup WB: NG2 proteoglycan expression by pericytes in pathological microvasculature. Microvasc Res 2002,63(1):129-134. 10.1006/mvre.2001.2376
13. Nishiyama A: Glial progenitor cells in normal and pathological states. Keio J Med 1998,47(4):205-208. 10.2302/kjm.47.205
14. Ong WY, Mackie K: A light and electron microscopic study of the CB1 cannabinoid receptor in the primate spinal cord. J Neurocytol 1999,28(1):39-45. 10.1023/A:1007011700677
15. Reynolds R, Cenci di Bello I, Dawson M, Levine J: The response of adult oligodendrocyte progenitors to demyelination in EAE. Prog Brain Res 2001, 132: 165-174.
16. Moransard M, Dann A, Staszewski O, Fontana A, Prinz M, Suter T: NG2 expressed by macrophages and oligodendrocyte precursor cells is dispensable in experimental autoimmune encephalomyelitis. Brain: J Neurology 2011,134(Pt 5):1315-1330. 10.1093/brain/awr070
17. Reynolds R, Dawson M, Papadopoulos D, Polito A, Di Bello IC, Pham-Dinh D, Levine J: The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS. J Neurocytol 2002,31(6-7):523-536.
18. Wilson HC, Scolding NJ, Raine CS: Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions. J Neuroimmunol 2006,176(1-2):162-173. 10.1016/j.jneuroim.2006.04.014
19. Hardy JA, Higgins GA: Alzheimer's disease: the amyloid cascade hypothesis. Science 1992,256(5054):184-185. 10.1126/science.1566067
20. Zetterberg H, Mattsson N, Shaw LM, Blennow K: Biochemical markers in Alzheimer's disease clinical trials. Biomark Med 2010,4(1):91-98. 10.2217/bmm.09.80
21. Brun A, Englund E: A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 1986,19(3):253-262. 10.1002/ana.410190306
22. Englund E, Brun A: White matter changes in dementia of Alzheimer's type: the difference in vulnerability between cell compartments. Histopathology 1990,16(5):433-439.
23. Mattson MP: Glutamate and neurotrophic factors in neuronal plasticity and disease. Ann N Y Acad Sci 2008, 1144: 97-112. 10.1196/annals.1418.005
24. Higgins GC, Beart PM, Shin YS, Chen MJ, Cheung NS, Nagley P: Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury. J Alzheimer's Dis: JAD 2010,20(Suppl 2):S453-S473. 10.3233/JAD-2010-100321
25. Jantaratnotai N, Ryu JK, Kim SU, McLarnon JG: Amyloid beta peptide-induced corpus callosum damage and glial activation in vivo. Neuroreport 2003,14(11):1429-1433. 10.1097/01.wnr.0000086097.47480.a0
26. Xu J, Chen S, Ahmed SH, Chen H, Ku G, Goldberg MP, Hsu CY: Amyloid-beta peptides are cytotoxic to oligodendrocytes. J Neuroscience: Official J Soc Neurosci 2001,21(1):RC118.
27. Takao T, Flint N, Lee L, Ying X, Merrill J, Chandross KJ: 17beta-estradiol protects oligodendrocytes from cytotoxicity induced cell death. J Neurochem 2004,89(3):660-673. 10.1111/j.1471-4159.2004.02370.x
28. Roth AD, Ramirez G, Alarcon R, Von Bernhardi R: Oligodendrocytes damage in Alzheimer's disease: beta amyloid toxicity and inflammation. Biol Res 2005,38(4):381-387.
29. Horiuchi M, Maezawa I, Itoh A, Wakayama K, Jin LW, Itoh T, Decarli C: Amyloid beta1-42 oligomer inhibits myelin sheet formation in vitro. Neurobiol Aging 2012,33(3):499-509. 10.1016/j.neurobiolaging.2010.05.007
30. Nielsen HM, Mulder SD, Belien JA, Musters RJ, Eikelenboom P, Veerhuis R: Astrocytic A beta 1-42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins. Glia 2010,58(10):1235-1246. 10.1002/glia.21004
31. Nielsen HM, Veerhuis R, Holmqvist B, Janciauskiene S: Binding and uptake of A beta1-42 by primary human astrocytes in vitro. Glia 2009,57(9):978-988. 10.1002/glia.20822
32. Sokolowski JD, Mandell JW: Phagocytic clearance in neurodegeneration. Am J Pathol 2011,178(4):1416-1428. 10.1016/j.ajpath.2010.12.051
33. Brunnstrom H, Englund E: Comparison of four neuropathological scales for Alzheimer's disease. Clin Neuropathol 2011,30(2):56-69.
34. Nishiyama A, Yu M, Drazba JA, Tuohy VK: Normal and reactive NG2+ glial cells are distinct from resting and activated microglia. J Neurosci Res 1997,48(4):299-312. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve%26db=PubMed%26dopt=Citation%26list_uids=9169856 10.1002/(SICI)1097-4547(19970515)48:4<299::AID-JNR2>3.0.CO;2-6
35. Paintlia MK, Paintlia AS, Khan M, Singh I, Singh AK: Modulation of peroxisome proliferator-activated receptor-alpha activity by N-acetyl cysteine attenuates inhibition of oligodendrocyte development in lipopolysaccharide stimulated mixed glial cultures. J Neurochem 2008,105(3):956-970. 10.1111/j.1471-4159.2007.05199.x
36. Pang Y, Campbell L, Zheng B, Fan L, Cai Z, Rhodes P: Lipopolysaccharide-activated microglia induce death of oligodendrocyte progenitor cells and impede their development. Neuroscience 2010,166(2):464-475. 10.1016/j.neuroscience.2009.12.040
37. Wu J, Yoo S, Wilcock D, Lytle JM, Leung PY, Colton CA, Wrathall JR: Interaction of NG2(+) glial progenitors and microglia/macrophages from the injured spinal cord. Glia 2010,58(4):410-422. 10.1002/glia.20932
38. Defaux A, Zurich MG, Honegger P, Monnet-Tschudi F: Minocycline promotes remyelination in aggregating rat brain cell cultures after interferon-gamma plus lipopolysaccharide-induced demyelination. Neuroscience 2011, 187: 84-92. 10.1016/j.neuroscience.2011.04.053
39. Di Bello IC, Dawson MR, Levine JM, Reynolds R: Generation of oligodendroglial progenitors in acute inflammatory demyelinating lesions of the rat brain stem is associated with demyelination rather than inflammation. J Neurocytol 1999,28(4-5):365-381.
40. Gao Q, Lu J, Huo Y, Baby N, Ling EA, Dheen ST: NG2, a member of chondroitin sulfate proteoglycans family mediates the inflammatory response of activated microglia. Neuroscience 2010,165(2):386-394. 10.1016/j.neuroscience.2009.10.022
41. Fang X, Burg MA, Barritt D, Dahlin-Huppe K, Nishiyama A, Stallcup WB: Cytoskeletal reorganization induced by engagement of the NG2 proteoglycan leads to cell spreading and migration. Mol Biol Cell 1999,10(10):3373-3387.
42. Alonso G: NG2 proteoglycan-expressing cells of the adult rat brain: possible involvement in the formation of glial scar astrocytes following stab wound. Glia 2005,49(3):318-338. 10.1002/glia.20121
43. Horky LL, Galimi F, Gage FH, Horner PJ: Fate of endogenous stem/progenitor cells following spinal cord injury. J Comp Neurol 2006,498(4):525-538. 10.1002/cne.21065
44. Leoni G, Rattray M, Butt AM: NG2 cells differentiate into astrocytes in cerebellar slices. Mol Cell Neurosci 2009,42(3):208-218. 10.1016/j.mcn.2009.07.007
45. Tatsumi K, Haga S, Matsuyoshi H, Inoue M, Manabe T, Makinodan M, Wanaka A: Characterization of cells with proliferative activity after a brain injury. Neurochem Int 2005,46(5):381-389. 10.1016/j.neuint.2004.12.007
46. Tripathi RB, Rivers LE, Young KM, Jamen F, Richardson WD: NG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease. J Neuroscience: Official J Soc For Neurosci 2010,30(48):16383-16390. 10.1523/JNEUROSCI.3411-10.2010
47. Stallcup WB, Huang FJ: A role for the NG2 proteoglycan in glioma progression. Cell Adh Migr 2008,2(3):192-201. 10.4161/cam.2.3.6279
48. Karram K, Chatterjee N, Trotter J: NG2-expressing cells in the nervous system: role of the proteoglycan in migration and glial-neuron interaction. J Anat 2005,207(6):735-744. 10.1111/j.1469-7580.2005.00461.x
49. Stegmuller J, Werner H, Nave KA, Trotter J: The proteoglycan NG2 is complexed with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by the PDZ glutamate receptor interaction protein (GRIP) in glial progenitor cells. Implications for glial-neuronal signaling. J Biol Chem 2003,278(6):3590-3598. 10.1074/jbc.M210010200
50. Kucharova K, Chang Y, Boor A, Yong VW, Stallcup WB: Reduced inflammation accompanies diminished myelin damage and repair in the NG2 null mouse spinal cord. J Neuroinflammation 2011, 8: 158. 10.1186/1742-2094-8-158
51. Zhu X, Hill RA, Dietrich D, Komitova M, Suzuki R, Nishiyama A: Age-dependent fate and lineage restriction of single NG2 cells. Development 2011,138(4):745-753. 10.1242/dev.047951
52. Bouslama-Oueghlani L, Wehrle R, Sotelo C, Dusart I: Heterogeneity of NG2-expressing cells in the newborn mouse cerebellum. Dev Biol 2005,285(2):409-421. 10.1016/j.ydbio.2005.07.003
53. Psachoulia K, Jamen F, Young KM, Richardson WD: Cell cycle dynamics of NG2 cells in the postnatal and ageing brain. Neuron Glia Biol 2009,5(3-4):57-67. 10.1017/S1740925X09990354
54. Peters A, Verderosa A, Sethares C: The neuroglial population in the primary visual cortex of the aging rhesus monkey. Glia 2008,56(11):1151-1161. 10.1002/glia.20686
55. Weigand SD, Vemuri P, Wiste HJ, Senjem ML, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS, Jack CR Jr: Transforming cerebrospinal fluid Abeta42 measures into calculated Pittsburgh Compound B units of brain Abeta amyloid. Alzheimer's & dementia: J Alzheimer's Assoc 2011,7(2):133-141. 10.1016/j.jalz.2010.08.230
56. Wennstrom M, Hellsten J, Ekstrand J, Lindgren H, Tingstrom A: Corticosterone-induced inhibition of gliogenesis in rat hippocampus is counteracted by electroconvulsive seizures. Biol Psychiatry 2006,59(2):178-186. 10.1016/j.biopsych.2005.08.032
57. Wennstrom M, Hellsten J, Ekdahl CT, Tingstrom A: Electroconvulsive seizures induce proliferation of NG2-expressing glial cells in adult rat hippocampus. Biol Psychiatry 2003,54(10):1015-1024. S0006322303006930
58. Wennstrom M, Hellsten J, Tingstrom A: Electroconvulsive seizures induce proliferation of NG2-expressing glial cells in adult rat amygdala. Biol Psychiatry 2004,55(5):464-471. 10.1016/j.biopsych.2003.11.011
59. Orre K, Wennstrom M, Tingstrom A: Chronic lithium treatment decreases NG2 cell proliferation in rat dentate hilus, amygdala and corpus callosum. Prog Neuropsychopharmacol Biol Psychiatry 2009,33(3):503-510. 10.1016/j.pnpbp.2009.01.015
60. Komitova M, Perfilieva E, Mattsson B, Eriksson PS, Johansson BB: Enriched environment after focal cortical ischemia enhances the generation of astroglia and NG2 positive polydendrocytes in adult rat neocortex. Exp Neurol 2006,199(1):113-121. 10.1016/j.expneurol.2005.12.007
61. Islam MS, Tatsumi K, Okuda H, Shiosaka S, Wanaka A: Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions. Neurochem Int 2009,54(3-4):192-198. 10.1016/j.neuint.2008.10.011
62. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P: Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007,6(8):734-746. http://www.ncbi.nlm.nih.gov/pubmed/17616482 10.1016/S1474-4422(07)70178-3
63. Imai Y, Ibata I, Ito D, Ohsawa K, Kohsaka S: A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun 1996,224(3):855-862. 10.1006/bbrc.1996.1112
64. Joo NE, Watanabe T, Chen C, Chekenya M, Stallcup WB, Kapila YL: NG2, a novel proapoptotic receptor, opposes integrin alpha4 to mediate anoikis through PKCalpha-dependent suppression of FAK phosphorylation. Cell Death Differ 2008,15(5):899-907. 10.1038/cdd.2008.22
65. Lim SD, Stallcup W, Lefkove B, Govindarajan B, Au KS, Northrup H, Lang D, Fisher DE, Patel A, Amin MB, Arbiser JL: Expression of the neural stem cell markers NG2 and L1 in human angiomyolipoma: are angiomyolipomas neoplasms of stem cells? Mol Med 2007,13(3-4):160-165. http://www.ncbi.nlm.nih.gov/pubmed/17592550
66. Wen Y, Makagiansar IT, Fukushi J, Liu FT, Fukuda MN, Stallcup WB: Molecular basis of interaction between NG2 proteoglycan and galectin-3. J Cell Biochem 2006,98(1):115-127. 10.1002/jcb.20768
67. Nishiyama A, Dahlin KJ, Stallcup WB: The expression of NG2 proteoglycan in the developing rat limb. Development 1991,111(4):933-944.
68. Stallcup WB, Dahlin-Huppe K: Chondroitin sulfate and cytoplasmic domain-dependent membrane targeting of the NG2 proteoglycan promotes retraction fiber formation and cell polarization. J Cell Sci 2001,114(Pt 12):2315-2325.
69. Tillet E, Ruggiero F, Nishiyama A, Stallcup WB: The membrane-spanning proteoglycan NG2 binds to collagens V and VI through the central nonglobular domain of its core protein. J Biol Chem 1997,272(16):10769-10776. 10.1074/jbc.272.16.10769
70. Korzeniewski C, Callewaert DM: An enzyme-release assay for natural cytotoxicity. J Immunol Methods 1983,64(3):313-320. 10.1016/0022-1759(83)90438-6
71. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH: The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & dementia: J Alzheimer's Assoc 2011,7(3):263-269. 10.1016/j.jalz.2011.03.005
72. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975,12(3):189-198. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve%26db=PubMed%26dopt=Citation%26list_uids=1202204 10.1016/0022-3956(75)90026-6